The Pharmaceutical Industry & Claroty

Leading pharmaceutical companies rely on Claroty to safeguard their operational availability, integrity, and safety while tackling some of the toughest OT security challenges.

Resource

Multinational Pharmaceutical Company Inoculates Its OT Environment with Claroty

A global pharmaceutical company with ample intellectual property understood the importance of protecting its production operations.

Read More
Resource

OT Cyber Threat Landscape, Q1 2020

The first several months of 2020 have brought forth numerous notable events and complex threats of great significance to industrial enterprises, critical infrastructure, and other organizations that rely on OT networks.

Read More
Resource

Secure Remote Access: Data Sheet

Claroty Secure Remote Access (SRA) minimizes the risks remote users, including employees and 3rd party vendors, introduce to OT networks.

Read More
Resource

Introduction to Claroty

If improving security for your OT network is a priority or you just want to learn more about the state-of-the-art platform in industrial cybersecurity, this is a great introduction to Claroty.

Read More

Challenge: Asset Identification & Management

Mergers and acquisitions are common in the pharmaceutical industry and bring greater complexity to asset management, often resulting in a patchwork of legacy systems, unfamiliar devices, and ample intellectual property. Claroty CTD helps pharmaceutical companies effectively identify and manage their critical assets despite these conditions.

Learn How

Challenge: Security Monitoring & Threat Detection

Efficient detection of potential threats is crucial to preserving OT availability, integrity, and safety, as well as to protecting the industry’s intellectual property from adversaries seeking to steal it. Claroty’s monitoring capabilities enable it to rapidly detect the adversary tactics and techniques in the MITRE ATT&CK for ICS framework.

Learn How

Challenge: OT Remote & Third-Party Access

Typically heavy reliance on third-party vendors to service OT assets means that many pharmaceutical companies’ OT environments are frequently accessed remotely. Given that OT remote access is a common attack vector, this introduces significant risks to critical operations and invaluable intellectual property. Claroty SRA minimizes these risks.

Learn How

Challenge: Fundamental OT Security Controls

Effective OT security in the pharmaceutical industry requires enforcing fundamental controls that reduce risks to critical assets, infrastructure, and operations. The Claroty Platform provides extensive support for all five categories of security controls recommended by the NIST Cybersecurity Framework: Identify, Protect, Detect, Respond, Recover.

Learn How

What Pharmaceutical Customers are Saying

“We have existing relationships with Rockwell, Siemens and Schneider Electric, all three of whom endorsed Claroty for our OT security challenge. Those endorsements were a huge factor in our decision, as was the fact that Claroty was able to give us the best view into our asset inventory we’ve ever had.”

Multinational Pharmaceutical Company
Read More

Want to learn more? Request a Demo

Contact us to learn how Claroty can help your organization strengthen security, mitigate risk, and protect OT availability, integrity, and safety.